Clinical Trials Sponsored by Institut Guttmann

Total 74295 results

Institut Curie

Recruiting

Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4 (ALCINA4)

Cancer

France
Institut Curie

Recruiting

Exenteration: Quality of Life Study and Rehabilitation Rate According to the Reconstruction Technique (ETRE) (ETRE)

Cancer

France
Institut Curie

Recruiting

Real Life Study Evaluating the Clinical and Organisational Impact of Moovcare® Lung Connected Medical Device in Lung Cancer Patients : REAL-MOOV-LUNG (REAL-MOOV-LUNG)

Lung Cancer

France
Institut Bergonié

Recruiting

Impact of Specific Monitoring of Intraoperative Analgesia Under General Anesthesia on Chronic Pain After Ovarian Cancer Surgery (MONIALC)

Ovarian Neoplasm

France
Institut Pasteur

Recruiting

Study of the Incidence of Jarisch-Herxheimer Reaction in Leptospirosis Patients in New Caledonia (LEPJARNC)

Leptospirosis | Jarisch Herxheimer Reaction

New Caledonia
Institut Curie

Recruiting

First-in-human Phase I to Evaluate PEP-010 as Single Agent and in Combination With Paclitaxel or With Gemcitabine (CleverPeptide)

Metastatic Solid Tumor Cancer

France
Institut Curie

Recruiting

Chemotherapy Monitoring by ctDNA in HER2- Metastatic Breast Cancer (MONDRIAN)

HER2-negative Metastatic Breast Cancer

France
Institut Pasteur

Recruiting

Creation of a Prospective Cohort of Healthy and Sick Subjects and of a Collection of Associated Biological Resources, for the Study of the Immune System and of Its Genetic and Environmental Determinants. (CoSImmGEn)

Immune System and Related Disorders

France
Institut Pasteur

Recruiting

Simian Foamy Virus Transmission to Humans

Simian Foamy Virus Infection (Disorder)

Cameroon
Institut Curie

Recruiting

Prospective Biobanking Study in Ovarian, Breast, Head and Neck and Cervical Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE) (SCANDARE)

Cervical Cancer | Head and Neck Cancer | Ovarian Cancer | Triple-Negative Breast Cancer

France
Institut Bergonié

Recruiting

Regional Central Database Recording of Chronic Myeloid Leukemia (LMC)

Chronic Myeloid Leukemia

France
Institut Curie

Terminated

Study to Assess the Impact of Personalized Coaching on the Time Period and Quality of Return to Work After Breast Cancer (OPTICOACH)

Breast Cancer | Surgery

France
Institut Rafael

Active, not recruiting

Patient Preference Between a Prefilled Syringe or a Prefilled Pen Device for Administration of Pegfilgrastim (PELGRAZ)

Patient Satisfaction | Patient Preference | Febrile Neutropenia, Drug-Induced

France
Institut Curie

Active, not recruiting

SHIVA02 - Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer Using Each Patient as Its Own Control (SHIVA02) (SHIVA02)

Cancer | Solid Tumor, Adult

France
Institut Curie

Active, not recruiting

The Integrated Support and Palliative in Cancer Day-care Hospital for Patients With Advanced Cancers: Impact on Quality of Life, Care Pathways and Support for Caregivers (HDJ-SPI)

Cancer, Advanced

France
Institut Curie

Active, not recruiting

Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT Tracers (PROTONCHORDE01)

Skull Base Chordoma | Vertebral Chordoma

France
Institut Curie

Completed

Use of Specific Genetic Alteration s of Tumoral Cells Identified by the Next Generation Sequencing Techniques (NGS) to Follow Peripheral Samples of Children With Metastatic and/or High Risk Solid Tumor - NGSKids (NGSKids)

Metastatic and/or High Risk Solid Tumor of Children

France
Institut Curie

Completed

Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma

Choroidal Melanoma, Diffuse

France
Institut Curie

Completed

Circulating Tumoral DNA in Choroidal Melanoma (ctDNA MU) (ctDNA MU)

Choroidal Melanoma

France
Institut Bergonié

Active, not recruiting

Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients (OPTIMUNELUNG)

Non Small Cell Lung Cancer

France
Institut Curie

Completed

MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgery

Malignant Neoplasm of Breast

France
Institut Curie

Active, not recruiting

Use of Virtual Reality Mask or Music Therapy for Analgesia and Anxiolytic Purpose When Totally IVAD for Chemotherapy Under Local Anesthesia (REVCCI)

Implanted Venous Access Device

France
Institut Pasteur

Terminated

Toi Même: a Mobile System for Measuring Bipolar Illness

Bipolar Disorder

France
Institut Curie

Active, not recruiting

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

Triple Negative Breast Cancer | Pediatric Cancer | Metastatic Uveal Melanoma | Luminal B Breast Cancer

France
Institut Pasteur

Completed

Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19] (COVID-OISE)

Covid19 | SARS (Severe Acute Respiratory Syndrome)

France
Institut Curie

Completed

Breast Cancer Risk After Diagnostic Gene Sequencing (BRIDGEScohort2)

Genetic Predisposition to Disease

France, Germany
Institut Bergonié

Completed

Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery (OMEGA)

Colorectal Cancer

France
Institut Bergonié

Completed

Efavirenz in Treating Patients With Metastatic Prostate Cancer (FAVE)

Prostate Cancer

France
Institut Pasteur

Completed

Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity (INECOC)

Squamous Cell Carcinoma of the Oral Cavity | Leukoplakia Oral

France
Institut Pasteur

Withdrawn

Neonatal Vaccination Against Hepatitis B in Africa - Sero-survey in Senegal (NeoVac2S)

Hepatitis B
Institut Bergonié

Completed

PET Scan and CT Scan in Evaluating Response in Patients Undergoing Radiofrequency Ablation for Lung Metastases (TEPARF)

Unspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer

France
Institut Bergonié

Completed

Ultrasound Liver Intraoperative Imaging With SonoVue® (ULIIS)

Liver Metastases From Colorectal Primary Cancer

France
Institut Bergonié

Completed

CAP'Onco : Psychological and Social Consultation of Professional Accompaniment in Oncology (CAP'ONCO)

Cancer

France
Institut Bergonié

Completed

PET Enhanced CT Scan Performance in Cancer (COMBITEP)

Cancer Disease Progression
Institut Bergonié

Unknown

Role of FDG-PET CT in the Management of Muscle Invasive Bladder Cancer (TEP Vessie)

Muscle Invasive Bladder Cancer

France
Institut Curie

Terminated

Innovation for Standard Identification of Insertional HPV Mutations and of Target Therapeutic Genes in Cervical Cancer: Towards Development of Personalized Biomarkers in Clinical Oncology (PAIR HPV)

Cervical Cancer

France
Institut Curie

Unknown

Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers

Ductal Infiltrating Metastatic Breast Cancer | Hormone-receptors Positive Breast Cancer

France
Institut Curie

Completed

Test Semiquantitative Prostate Specific Antigen (PSA)

Prostatic Neoplasms | Prostatic Diseases | Prostate Cancer

France
Institut Curie

Completed

Optimizing the Care Pathways of Patients Treated for Operable Breast. (OPTIsoins01)

Breast Cancer | Surgery

France
Institut Curie

Completed

Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage IB, Stage II, or Stage IIIB Cervical Cancer (CETUXICOL)

Cervical Cancer

France
Institut Curie

Unknown

A Randomized Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Patients With Refractory Cancer (SHIVA)

Reccurent/Metastatic Solid Tumor Disease

France
Institut Curie

Unknown

Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology (CTC-CEC-ADN)

Solid Tumor.

France
Institut Bergonié

Completed

Evolution Natriuretic Peptide Concentrations of B-type (BNP) During General Anesthesia Under Propofol and Sevoflurane Association in Patients Previously Sensitized to Anthracyclines (PEPNATB)

Breast Cancer

France
Institut Bergonié

Completed

Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery (ROPAL 1)

Cancer | Postoperative Pain

France
Institut Pasteur

Completed

Genetic & Environmental Determinants Of Immune Phenotype Variance: Establishing A Path Towards Personalized Medicine (LabExMI)

Individuality

France
Institut Bergonié

Completed

Administration of Ketamine to Prevent the Post-operative Pain (KETAMINE)

Breast Cancer | Postoperative Pain

France
Institut Bergonié

Completed

Role of FCγRIIIA and FCγRIIA Receptor Polymorphisms (FCRVADS)

Upper Gingival Squamous Cell Carcinoma

France
Institut Curie

Completed

Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma (HPOB)

Carcinoma, Basal Cell

France
Institut Català d'Oncologia
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; Mario Negri Institute... and other collaborators

Completed

Health Effects of Secondhand Smoke Exposure in Outdoor Smoking Areas in Patients With COPD and Asthma ( TackSHSWP5 ) (TackSHSWP5)

Asthma | COPD | Second Hand Tobacco Smoke
Lawson Health Research Institute
Canadian Institutes of Health Research (CIHR); Berry Consultants; Weston Brain...

Active, not recruiting

Intranasal Oxytocin for Frontotemporal Dementia (FOXY)

Frontotemporal Dementia

United States, Canada

3

Subscribe